Literature DB >> 19651058

Disappearance of racial disparities in gastrointestinal stromal tumor outcomes.

Michael C Cheung1, Ying Zhuge, Relin Yang, Leonidas G Koniaris.   

Abstract

BACKGROUND: The purpose of this study was to determine the effects of race, socioeconomic status, and demographic and clinical variables on the outcomes of gastrointestinal stromal tumors (GISTs). STUDY
DESIGN: The Surveillance, Epidemiology, and End Results (SEER) database was queried for GIST and other intestinal mesenchymal tumors from 1992 to 2005.
RESULTS: A total of 3,795 patients with mesenchymal tumors were identified. More than 88% of tumors were identified as GIST after the year 2000. Overall, patient demographics showed 53% men, 72.2% Caucasians, 15.6% African Americans, and 9.1% Hispanics. In patients diagnosed before the year 2000, 30-day surgical mortality was higher in African Americans (0.56% versus 0.76% Caucasians, p=0.012), although no difference was observed in tumor stage (p=0.446) or grade (p=0.495). African Americans underwent surgical extirpation less frequently (p=0.003). Multivariate analysis correcting for patient demographics, socioeconomic status, and clinical data demonstrated African-American race (hazards ratio 1.66, p < 0.001) and failure to undergo surgical extirpation (hazards ratio 2.930, p < 0.001) were independent predictors of poor prognosis. In patients diagnosed after 2000, 30-day surgical mortality was equivalent between races (0.46% versus 0.35%, p=0.517), and African Americans underwent surgical extirpation just as often as Caucasians did (p=0.153). Multivariate analysis for patients diagnosed after 2000 demonstrated no difference in survival by race (hazards ratio 1.27, p=0.126).
CONCLUSIONS: Before 2000, African Americans were less likely to have surgery, and they demonstrated an overall increased mortality rate for GIST. Since 2000, African Americans have benefited from increased surgical resection rates, decreased perioperative mortality, and improved longterm survival. These changes have appeared to erase racial disparities in the treatment of GIST.

Entities:  

Mesh:

Year:  2009        PMID: 19651058     DOI: 10.1016/j.jamcollsurg.2009.03.018

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

1.  Understanding the critical role for surgery in the management of wild-type gastrointestinal stromal tumor (GIST).

Authors:  Bradford J Kim; Joshua K Kays; Leonidas G Koniaris; Nakul P Valsangkar
Journal:  Transl Gastroenterol Hepatol       Date:  2017-11-15

2.  Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study.

Authors:  Grace L Ma; James D Murphy; Maria E Martinez; Jason K Sicklick
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-02       Impact factor: 4.254

3.  Racial Disparity in Incidence and Survival for Gastrointestinal Stromal Tumors (GISTs): an Analysis of SEER Database.

Authors:  Mark B Ulanja; Mohit Rishi; Bryce D Beutler; Kenneth G Konam; Santhosh Ambika; Tomas Hinojosa; Francis T Djankpa; Wei Yang; Nageshwara Gullapalli
Journal:  J Racial Ethn Health Disparities       Date:  2019-06-18

4.  Inpatient burden of gastrointestinal stromal tumors in the United States.

Authors:  Manasi Datar; Rahul Khanna
Journal:  J Gastrointest Oncol       Date:  2012-12

5.  Colonic Gastrointestinal Stromal Tumor: A Population-Based Analysis of Incidence and Survival.

Authors:  Zhiqiang Liu; Yan Sun; Yongfeng Li; Jingyuan Zhao; Shihong Wu; Zibo Meng; Heshui Wu
Journal:  Gastroenterol Res Pract       Date:  2019-04-11       Impact factor: 2.260

6.  Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants.

Authors:  Katie M O'Brien; Irene Orlow; Cristina R Antonescu; Karla Ballman; Linda McCall; Ronald DeMatteo; Lawrence S Engel
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.